KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Net Cash Flow: 2010-2025

Historic Net Cash Flow for Opko Health (OPK) over the last 15 years, with Sep 2025 value amounting to $143.8 million.

  • Opko Health's Net Cash Flow fell 61.84% to $143.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.1 million, marking a year-over-year decrease of 96.01%. This contributed to the annual value of $352.9 million for FY2024, which is 711.62% up from last year.
  • According to the latest figures from Q3 2025, Opko Health's Net Cash Flow is $143.8 million, which was up 186.76% from -$165.7 million recorded in Q2 2025.
  • Opko Health's Net Cash Flow's 5-year high stood at $376.8 million during Q3 2024, with a 5-year trough of -$165.7 million in Q2 2025.
  • Its 3-year average for Net Cash Flow is $25.0 million, with a median of -$2.4 million in 2023.
  • Data for Opko Health's Net Cash Flow shows a peak YoY increase of 1,090.96% (in 2024) and a maximum YoY decrease of 1,391.73% (in 2024) over the last 5 years.
  • Over the past 5 years, Opko Health's Net Cash Flow (Quarterly) stood at -$13.5 million in 2021, then slumped by 117.57% to -$29.3 million in 2022, then tumbled by 48.10% to -$43.5 million in 2023, then soared by 171.57% to $31.1 million in 2024, then crashed by 61.84% to $143.8 million in 2025.
  • Its Net Cash Flow stands at $143.8 million for Q3 2025, versus -$165.7 million for Q2 2025 and $2.0 million for Q1 2025.